FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1226-1227 November 3, 1994 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In 1992 the direct costs of diabetes mellitus and its complications in the United States were estimated at a staggering $45 billion,¹ more than the total annual cost of the British National Health Service. Preventing this disease and especially its complications would greatly lighten both the human and the economic burdens it imposes. The landmark Diabetes Control and Complications Trial showed convincingly the protective value of blood glucose control in patients with insulin-dependent diabetes,² and it is likely that the results are applicable to the equally vulnerable and much more numerous group of patients with non-insulin-dependent diabetes mellitus (NIDDM). If . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Glueck, C. J., Moreira, A., Goldenberg, N., Sieve, L., Wang, P. (2003). Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin. Hum Reprod 18: 1618-1625 [Abstract] [Full Text]  
• Duncan, A. C., Lyall, H., Roberts, R.N., Petrie, J. R., Perera, M. J., Monaghan, S., Hart, D. M., Connell, J. M. C., Lumsden, M. A. (1999). The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women. J. Clin. Endocrinol. Metab. 84: 2402-2407 [Abstract] [Full Text]  
• Reusch, J. E-B. (1998). Focus on Insulin Resistance in Type 2 Diabetes: Therapeutic Implications. The Diabetes Educator 24: 188-193